In today’s recent session, 0.4 million shares of the Clover Health Investments Corp (NASDAQ:CLOV) have been traded, and its beta is 2.00. Most recently the company’s share price was $3.84, and it changed around $0.03 or 0.90% from the last close, which brings the market valuation of the company to $1.96B. CLOV at last check was trading at a discount to its 52-week high of $4.87, offering almost -26.82% off that amount. The share price’s 52-week low was $0.61, which indicates that the recent value has risen by an impressive 84.11% since then. We note from Clover Health Investments Corp’s average daily trading volume that its 10-day average is 5.33 million shares, with the 3-month average coming to 6.15 million.

Clover Health Investments Corp stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended CLOV as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Clover Health Investments Corp is expected to report earnings per share of -0.07 for the current quarter.

Clover Health Investments Corp (NASDAQ:CLOV) trade information

Instantly CLOV has been showing a green trend so far today with a performance of 0.90% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.85 on recent trading dayincreased the stock’s daily price by 0.26%. The company’s shares are currently up 22.03% year-to-date, but still up 0.90% over the last five days. On the other hand, Clover Health Investments Corp (NASDAQ:CLOV) is -8.04% down in the 30-day period. We can see from the shorts that 11.9 million shares have been sold at a short interest cover period of 2.24 day(s).

The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 36.0% from its current value. Analyst projections state that CLOV is forecast to be at a low of $6 and a high of $6.

Clover Health Investments Corp (CLOV) estimates and forecasts

The year-over-year growth rate is expected to be 36.00%, up from the previous year.

Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 466.93M in revenue for the current quarter. 4 analysts expect Clover Health Investments Corp to make 474.88M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 346.92M and 356.26M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 34.59%. Forecasts for the next quarter put sales growth at 33.30%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -237.67%. Clover Health Investments Corp earnings are expected to increase by -80.25% in 2025, but the outlook is positive 40.98% per year for the next five years.

Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 5.09% of Clover Health Investments Corp shares, and 22.38% of them are in the hands of institutional investors. The stock currently has a share float of 23.58%. Clover Health Investments Corp stock is held by 214.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.5662% of the shares, which is about 17.35 million shares worth $21.33 million.

RENAISSANCE TECHNOLOGIES LLC, with 2.3123% or 11.27 million shares worth $13.86 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 10.96 shares worth $41.74 million, making up 2.62% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 6.22 shares worth around $23.67 million, which represents about 1.49% of the total shares outstanding.